title: Bacteremic pneumococcal pneumonia in HIV-seropositive and HIV-seronegative adults.
abstract: OBJECTIVE
  To compare the demographic, clinical, laboratory, and microbiological data, and the hospital course and outcome of HIV-seropositive and HIV-seronegative adults with bacteremic pneumococcal pneumonia.
  
  
  METHODS
  Retrospective observation study conducted over a 2-year period.
  
  
  METHODS
  Academic teaching hospital attached to the University of the Witwatersrand, Johannesburg, South Africa.
  
  
  METHODS
  Consecutive patients with bacteremic pneumococcal pneumonia were identified on the basis of positive blood culture results.
  
  
  METHODS
  All available demographic, clinical, routine laboratory, radiographic, and microbiological data were recorded retrospectively for each of the patients, and the combined data for the HIV-seropositive patients were compared with those of the HIV-seronegative patients.
  
  
  RESULTS
  A total of 112 patients (31 HIV-seropositive and 81 HIV-seronegative patients) were entered into the study. The HIV-seropositive patients were significantly younger than the HIV-seronegative patients (32.8 vs 39.6 years old) and had lower admission hemoglobin (11.8 vs 13.4 g/dL), WBC count (10.3 vs 14.3 x 10(9)/L), serum albumin (31 vs 36 g/L), sodium (129 vs 132 mmol/L), and potassium (3.0 vs 3.5 mmol/L), respectively. Although the HIV-seropositive patients appeared to have more multilobar pulmonary consolidation on the chest radiograph than the HIV-seronegative patients (60% vs 34%), this did not quite reach statistical significance. In addition, the HIV-seropositive patients had significantly more infections (48.4% vs 20.8%) with pneumococcal serogroups/serotypes (serogroups 6, 19, 23, and serotype 14) that are found more commonly in children, and they also had more penicillin-resistant isolates (13% vs 2.5%) than the HIV-seronegative patients, respectively. Similarly, it was noted that when these data were analyzed according to gender (irrespective of HIV status), women had significantly more infections than men (47% vs 21%) with serogroups/serotypes that are usually found in children, more penicillin-resistant isolates (15% vs 1%), and more co-trimoxazole-resistant isolates (21% vs 5%), respectively. There were no differences noted in any of the other parameters, including initial APACHE (acute physiology and chronic health evaluation) II score, PaO2/fraction of inspired oxygen ratio, duration of temperature, duration of IV therapy, duration of hospitalization, complications, and outcome, when comparing HIV-seropositive and HIV-seronegative patients. Two patients in each group died.
  
  
  CONCLUSIONS
  The clinical features of bacteremic pneumococcal pneumonia are similar in HIV-seropositive and HIV-seronegative patients. Although differences are noted in various laboratory and microbiological parameters, they do not appear to have an impact on outcome.
authors.affiliation: Department of Medicine, Hillbrow Hospital, University of the Witwatersrand, Johannesburg, South Africa. 014charl@chiron.wits.ac.za
authors.forename: C
authors.initials: C
authors.lastname: Feldman
authors.forename: M
authors.initials: M
authors.lastname: Glatthaar
authors.forename: R
authors.initials: R
authors.lastname: Morar
authors.forename: A G
authors.initials: AG
authors.lastname: Mahomed
authors.forename: S
authors.initials: S
authors.lastname: Kaka
authors.forename: M
authors.initials: M
authors.lastname: Cassel
authors.forename: K P
authors.initials: KP
authors.lastname: Klugman
mesh_terms: D018806:APACHE; D000328:Adult; D016470:Bacteremia / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology; D016022:Case-Control Studies; D005260:Female; D018023:HIV Seronegativity; D006679:HIV Seropositivity / Q000453:epidemiology / Q000382:microbiology; D006801:Humans; D008297:Male; D011018:Pneumonia, Pneumococcal / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology*; D012189:Retrospective Studies; D013019:South Africa / Q000453:epidemiology; D013296:Streptococcus pneumoniae / Q000145:classification / Q000187:drug effects